Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design.
Fiche publication
Date publication
avril 2017
Journal
BMC nephrology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Thilly N, Chanliau J, Frimat L, Combe C, Merville P, Chauveau P, Bataille P, Azar R, Laplaud D, Noël C, Kessler M
Lien Pubmed
Résumé
Home telemonitoring has developed considerably over recent years in chronic diseases in order to improve communication between healthcare professionals and patients and to promote early detection of deteriorating health status. In the nephrology setting, home telemonitoring has been evaluated in home dialysis patients but data are scarce concerning chronic kidney disease (CKD) patients before and after renal replacement therapy. The eNephro study is designed to assess the cost effectiveness, clinical/biological impact, and patient perception of a home telemonitoring for CKD patients. Our purpose is to present the rationale, design and organisational aspects of this study.
Mots clés
Blood Pressure Determination, Body Weight, Clinical Laboratory Services, Communication, Cost-Benefit Analysis, Delivery of Health Care, economics, Disease Management, Electronic Health Records, France, General Practice, Humans, Internet, Kidney Failure, Chronic, physiopathology, Kidney Transplantation, Nephrology, Physician-Patient Relations, Renal Dialysis, Renal Insufficiency, Chronic, economics, Severity of Illness Index, Symptom Assessment, Telemedicine, economics
Référence
BMC Nephrol. 2017 04 5;18(1):126